Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global $71Bn Vaccines Market Review 2016-2019 and Forecast to 2026 - ResearchAndMarkets.com

November 20, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Nov 20, 2019--

The “Global Vaccines Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.

The Global Vaccines market is expected to reach $71.04 billion by 2026 growing at a CAGR of 8.7% from 2018 to 2026.

Factors such as rise in prevalence of diseases, increasing government initiatives towards immunization and increasing number of prospects from the developing economies are driving the market growth. Though, high cost of development and complexities related to manufacturing are projected to inhibit the growth of the market. Moreover, high growth prospects in emerging markets may provide ample opportunities for the market growth.

By technology, recombinant vaccines segment acquired significant growth in the market owing to less side-effect of these vaccines in comparison to conventional ones. They are largely used in animals for prevention of diseases such as pneumonia, foot and mouth disease, septicaemia and pox disease that will further support the business growth. Developments in the field of molecular biology and genetic engineering will positively impact the growth of market.

The key vendors mentioned are Emergent Biosolutions, Glaxosmithkline, Pfizer, Sanofi Pasteur, Merck, Medimmune, LLC (A Subsidiary of Astrazeneca), CSL Limited, Serum Institute of India, Johnson & Johnson, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma, Panacea Biotec, Bavarian Nordic, Biological E and Daiichi Sankyo Company.

Key Questions Answered in this Report

Key Topics Covered

1 Market Synopsis

2 Research Outline

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

5 Global Vaccines Market, By Patient Type

5.1 Introduction

5.2 Pediatric Patients

5.3 Adult Patients

6 Global Vaccines Market, By Type

6.1 Introduction

6.2 Monovalent Vaccines

6.3 Multivalent Vaccines

7 Global Vaccines Market, By Route of Administration

7.1 Introduction

7.2 Oral Administration

7.3 Intramuscular and Subcutaneous Administration

7.4 Injectable

7.5 Other Routes of Administration

8 Global Vaccines Market, By Indication

8.1 Introduction

8.2 Foot and Mouth Disease

8.3 Respiratory Syncytial Virus (RSV)

8.4 Cancer

8.5 Cholera

8.6 Human Papilloma Virus (HPV)

8.7 Influenza

8.8 Diphtheria, Pertussis, and Tetanus (DPT)

8.9 Meningococcal Disease

8.10 Hepatitis

8.11 Varicella

8.12 Herpes Zoster

8.13 Measles, Mumps, and Rubella (MMR)

8.14 Dengue

8.15 Rotavirus

8.16 Pneumococcal Disease

8.17 Polio

8.18 Disease

9 Global Vaccines Market, By Technology

9.1 Introduction

9.2 Attenuated Vaccines

9.3 Recombinant Vaccines

9.4 Inactivated & Subunit Vaccines

9.5 Toxoid Vaccines

9.6 Live Attenuated Vaccines

9.7 Conjugate Vaccines

10 Global Vaccines Market, By Distribution Channel

10.1 Introduction

10.2 Retail Pharmacies

10.3 Institutional Sale

10.4 Hospital Pharmacies

11 Global Vaccines Market, By End User

11.1 Introduction

11.2 Pediatric Vaccines

11.3 Traveler Vaccines

11.4 Adult Vaccines

10 Global Vaccines Market, By Geography

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 South America

10.6 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape

12.1 Emergent Biosolutions

12.2 Glaxosmithkline

12.3 Pfizer

12.4 Sanofi Pasteur

12.5 Merck

12.6 Medimmune, LLC (A Subsidiary of Astrazeneca)

12.7 CSL Limited

12.8 Serum Institute of India

12.9 Johnson & Johnson

12.10 Mitsubishi Tanabe Pharma Corporation

12.11 Astellas Pharma

12.12 Panacea Biotec

12.13 Bavarian Nordic

12.14 Biological E

12.15 Daiichi Sankyo Company

For more information about this report visit https://www.researchandmarkets.com/r/y1y6vk

View source version on businesswire.com:https://www.businesswire.com/news/home/20191120005791/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 11/20/2019 12:51 PM/DISC: 11/20/2019 12:51 PM